Example: dental hygienist

NEWS & ANALySIS

diseases and cardiovascular diseases tied for third, with 4 (8%) approvals each. CDER approvals included the 100th anti-body, two antibody–drug conjugates (ADCs), a bispecific antibody, a constrained peptide and two oligonucleotide drugs (Fig. 3). 34 drugs (68%) received priority review, for therapies that the FDA expects to offer

Tags:

  Drug, Review, Disease

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Advertisement

Related search queries